Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews

被引:42
|
作者
Rodriguez-Torres, Edgardo [1 ,2 ]
Gonzalez-Perez, Margarita M. [3 ]
Diaz-Perez, Clemente [4 ,5 ]
机构
[1] Univ Puerto Rico, Inst Stat, 501 Ave Univ,Suite 1525, Rio Piedras, PR 00925 USA
[2] Univ Puerto Rico, CIS, 501 Ave Univ,Suite 1525, Rio Piedras, PR 00925 USA
[3] Univ Puerto Rico, Sch Med Lib, Med Sci Campus Ret, Rio Piedras, PR USA
[4] Univ Puerto Rico, Sch Med, Med Sci Campus, Rio Piedras, PR USA
[5] Univ Puerto Rico, Hispan Alliance Clin & Translat Res, Med Sci Campus, Rio Piedras, PR USA
关键词
Clinical trials participation; Clinical trials recruitment; Clinical trials enrollment; Barriers to clinical trial participation; Facilitators to clinical trial participation; Overview of reviews; HIV VACCINE TRIALS; RANDOMIZED CONTROLLED-TRIALS; PATIENT PARTICIPATION; UNDERREPRESENTED POPULATIONS; HEALTHY-VOLUNTEERS; AFRICAN-AMERICANS; ETHNIC-MINORITIES; DECISION-MAKING; CANCER TRIAL; RECRUITMENT;
D O I
10.1016/j.conctc.2021.100829
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The demand for clinical trial participants is today one of the highest it has ever been and continues to increase. At the same time, subject recruitment continues to be problematic and the major reason for clinical trial premature terminations. The literature on clinical trial recruitment, which spans several decades and includes hundreds of studies, has an abundance of findings that can be synthesized by way of an overview to provide a well-informed and complete picture of the factors that determine subject participation. Objectives: An overview of the systematic reviews that report barriers and facilitators to clinical trial participation was conducted. The extracted data were synthesized, and a thematic framework of the factors that affect subject participation in clinical trials was developed. The overview extended across medical subjects and demographics. Methods: Thirty reviews that complied with the inclusion criteria were included. These reviews covered 753 relevant primary studies and reported 881 barriers and facilitators. The barriers and facilitators were thematically synthesized and a thematic framework of 20 themes was developed. The quality of the included reviews was assessed and reported. Main results: Several opportunities to increase clinical trial participation, by developing interventions and changing the trial design, derived from an analysis of the thematic framework. That analysis also showed that most of the 20 themes operate mainly as a barrier or as a facilitator, and that most have an effect across medical subjects. As to the quality elements assessed, some reviews complied almost fully but most only partially.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials
    Andrasik, Michele Peake
    Yoon, Ro
    Mooney, Jessica
    Broder, Gail
    Bolton, Marcus
    Votto, Teress
    Davis-Vogel, Annet
    PREVENTION SCIENCE, 2014, 15 (03) : 268 - 276
  • [22] Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials
    Michele Peake Andrasik
    Ro Yoon
    Jessica Mooney
    Gail Broder
    Marcus Bolton
    Teress Votto
    Annet Davis-Vogel
    Prevention Science, 2014, 15 : 268 - 276
  • [23] Barriers to and facilitators of health services utilisation by refugees in resettlement countries: an overview of systematic reviews
    Parajuli, Jamuna
    Horey, Dell
    AUSTRALIAN HEALTH REVIEW, 2020, 44 (01) : 132 - 142
  • [24] Barriers and facilitators to recruiting patients to clinical trials in HIV clinics
    Samuel, M.
    Davies, O.
    Darling, D.
    Tiraboschi, J.
    Jendrulek, I.
    Larbalestier, N.
    Fox, J.
    HIV MEDICINE, 2014, 15 : 22 - 22
  • [25] A National Survey of the barriers and facilitators to conducting Clinical Trials in Radiotherapy
    Roberts, D.
    Hutton, D.
    Taylor, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1656 - S1656
  • [26] Barriers and facilitators to discussion of cancer clinical trials: A qualitative study
    Castillo, Brenda Sofia
    Boehmer, Leigh
    Oyer, Randall A.
    Pierce, Lori J.
    Barrett, Nadine
    Guerra, Carmen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Minority HIV Patients' Perceptions of Barriers and Facilitators to Participation in Clinical Research
    Wolak, Caitlin
    Bass, Sarah B.
    Tedaldi, Ellen
    Vandenburg-Wolf, Mary
    Rohrer, Caitlin
    CURRENT HIV RESEARCH, 2012, 10 (04) : 348 - 355
  • [28] Re: Surveys identify barriers to participation in clinical trials
    Wagle, N
    Goldman, DP
    Kilgore, M
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (03) : 238 - 239
  • [29] Participation of the Elderly Population in Clinical Trials: Barriers and Solutions
    Denson, Aaron C.
    Mahipal, Amit
    CANCER CONTROL, 2014, 21 (03) : 209 - 214
  • [30] Barriers exist to patient participation in clinical trials.
    Guarino, MJ
    Masters, GA
    Schneider, CJ
    Biggs, DD
    Grubbs, SS
    Himelstein, AL
    Martin, SE
    Michaels, LM
    Guarino, AJ
    Rejtos, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 531S - 531S